SAN MATEO, Calif., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced that the previously ...

Vincerx Pharma (NASDAQ:VINC) just reported results for the fourth quarter of 2023. Vincerx Pharma reported earnings per share of -23 cents. This was above the analyst estimate for EPS of -37 cents.

In a turbulent market environment, Vincerx Pharma, Inc. (VINC) stock has reached its 52-week low, trading at $1.3. According to InvestingPro analysis, the company maintains a healthy current ratio ...

US Stocks Likely To Open Higher As Wall Street Watches Trump Tariff Talks: 'March, April, May Tend To Be Solid Months In Post-Election Years,' Says Expert US. stock futures rose on Monday ...

High-flying Kenyan rapper Khaligraph Jones has unveiled Khali Cartel 5 rap challenge. The development comes in the backdrop ...

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> ...

Nasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the ...

Vincerx Pharma (VINC) announced that the previously signed binding Term Sheet between Vincerx, Oqory, and Vivasor for a reverse merger ...